The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication
Open accessAbstract
BACKGROUND AND AIMS: Gastric intestinal metaplasia (IM) is generally considered to be a precancerous lesion in the gastric carcinogenesis cascade. This study identified the risk factors associated with progression of IM in a randomised control study. SUBJECTS AND METHODS: A total of 587 Helicobacter pylori infected subjects were randomised to receive a one week course of anti-Helicobacter therapy (omeprazole, amoxicillin, and clarithromycin (OAC)) or placebo. Subjects underwent endoscopy with biopsy at baseline and at five years. Severity of IM was graded according to the updated Sydney classification and progression was defined as worsening of IM scores at five years in either the antrum or corpus, or development of neoplasia. Backward stepwise multiple logistic regression was used to identify independent risk factors associated with IM progression. RESULTS: Of 435 subjects (220 in the OAC and 215 in the placebo group) available for analysis, 10 developed gastric cancer and three had dysplasia. Overall progression of IM was noted in 52.9% of subjects. Univariate analysis showed that persistent H pylori infection, age >45 years, male subjects, alcohol use, and drinking water from a well were significantly associated with IM progression. Duodenal ulcer and OAC treatment were associated with a reduced risk of histological progression. Progression of IM was more frequent in those with more extensive and more severe IM at baseline. With multiple logistic regression, duodenal ulcer (odds ratio (OR) 0.23 (95% confidence interval (CI) 0.09-0.58)) was found to be an independent protective factor against IM progression. Conversely, persistent H pylori infection (OR 2.13 (95% CI 1.41-3.24)), age >45 years (OR 1.92 (95% CI 1.18-3.11)), alcohol use (OR 1.67 (95% CI 1.07-2.62)), and drinking water from a well (OR 1.74 (95% CI 1.13-2.67)) were independent risk factors associated with IM progression. CONCLUSION: Eradication of H pylori is protective against progression of premalignant gastric lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
Helicobacter pylori Infection and the Development of Gastric Cancer
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa001999 · Cited by 4,465
Correa, P. (1992) · PubMed · Cited by 3,216
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
El-Omar, E. M., Carrington, M., Chow, W.-H., McColl, K. E. L., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C.-C., Rothman, N., et al. (2000) · Nature · doi:10.1038/35006081 · Cited by 2,366
Malfertheiner, P., Chan, F. K., & McColl, K. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60938-7 · Cited by 1,488
Helicobacter and Cancer Collaborative Group (2001) · Gut · doi:10.1136/gut.49.3.347 · Cited by 1,038
Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer
Huang, J.-Q., Sridhar, S., Chen, Y., & Hunt, R. H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70422-6 · Cited by 957
Correa, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1881 · Cited by 737
Uemura, N., Mukai, T., Okamoto, S., Yamaguchi, S., Mashiba, H., Taniyama, K., Sasaki, N., Haruma, K., Sumii, K., & Kajiyama, G. (1997) · PubMed · Cited by 546
Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia
Filipe, M. I., Muñoz, N., Matko, I., Kato, I., Pompe‐Kirn, V., Jutersek, A., Teuchmann, S., Benz, M., & Prijon, T. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570306 · Cited by 470
[Helicobacter pylori infection and development of gastric cancer].
Kamada, T., Kusunoki, H., Hata, J., et al. (2005) · PubMed · Cited by 425
Pathology and genetics of tumors of the digestive system
Yajnik, V. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)70019-4 · Cited by 384
Gastric Dysplasia: The Padova International Classification
Rugge, M., Correa, P., Dixon, M. F., Hattori, T., Leandro, G., Lewin, K., Riddell, R. H., Sipponen, P., & Watanabe, H. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200002000-00001 · Cited by 365
Helicobacter pylori Infection and the Development of Gastric Cancer
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200111000-00023 · Cited by 360
Sung, J. J. Y., Lin, S., Ching, J. Y. L., Zhou, L., To, K. F., Wang, R., Leung, W. K., NG, E. K. W., Lau, J. Y. W., Lee, Y. T., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.8550 · Cited by 351
Self-citationGastric Dysplasia and Gastric Cancer: Helicobacter pylori, Serum Vitamin C, and Other Risk Factors
You, W.-C. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1607 · Cited by 270
Rokkas, T., Filipe, M. I., & Sladen, G. E. (1991) · Gut · doi:10.1136/gut.32.10.1110 · Cited by 253
Ohkusa, T., Fujiki, K., Takashimizu, I., Kumagai, J., Tanizawa, T., Eishi, Y., Yokoyama, T., & Watanabe, M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-5-200103060-00010 · Cited by 205
Chan, F. K., & Leung, W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11030-0 · Cited by 200
Self-citationvan der Hulst, R., van der Ende, A., Dekker, F., Ten Kate, F., Weel, J., Keller, J., Kruizinga, S., Dankert, J., & Tytgat, G. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70076-3 · Cited by 186
Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer
You, W.-C., Li, J.-Y., Blot, W. J., Chang, Y.-S., Jin, M.-L., Gail, M. H., Zhang, L., Liu, W.-D., Ma, J.-L., Hu, Y.-R., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991126)83:5<615::aid-ijc8>3.0.co;2-l · Cited by 177
Intestinal metaplasia and gastric carcinogenesis
Leung, W. K., & Sung, J. J. Y. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01300.x · Cited by 167
Self-citationGastric intestinal metaplasia: subtypes and natural history
El-Zimaity, H. M. T., Ramchatesingh, J., Saeed, M. A., & Graham, D. Y. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.9.679 · Cited by 140
Zhou, L., Sung, J. J. �., Lin, S., Jin, Z., Ding, S., Huang, X., Xia, Z., Guo, H.-L., Liu, J., & Chao, W. (2003) · PubMed · Cited by 125
Pokharel, R. P., Maeda, K., Yamamoto, T., Noguchi, K., Iwai, Y., Nakamura, H., & Iijima, K. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199905)188:1<24::aid-path316>3.0.co;2-f · Cited by 24
Cited by
Pathogenesis of Helicobacter pylori Infection
Kusters, J. G., van Vliet, A. H. M., & Kuipers, E. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00054-05 · Cited by 2,526
“pylori eradication had in the first years of follow-up no significant effect on gastric cancer incidence (360, 421, 693).”
BackgroundManagement of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,266
Van Cutsem, E., Sagaert, X., Topal, B., Haustermans, K., & Prenen, H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30354-3 · Cited by 1,793
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection
Chey, W. D., Wong, B. C. Y., & Practice Parameters Committee of the American College of Gastroenterology (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01393.x · Cited by 1,406
de Vries, A. C., van Grieken, N. C. T., Looman, C. W. N., Casparie, M. K., de Vries, E., Meijer, G. A., & Kuipers, E. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.071 · Cited by 848
Metadata
- Authors
- Leung, W. K.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2004-09-01
- Volume
- 53
- Issue
- 9
- Pages
- 1244-1249
- ISSN
- 0017-5749 (ISSN-L)
- OpenAlex
- W2107288240
- Cited by
- 437
- References
- 25
- FWCI
- 20.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.